These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 1021239

  • 1. Phase II study of VP-16-213 versus dianhydrogalactitol in patients with metastatic malignant melanoma.
    Ahmann DL, Bisel HF, Edmonson JH, Hahn RG, O'Connell MJ, Frytak S.
    Cancer Treat Rep; 1976 Nov; 60(11):1681-2. PubMed ID: 1021239
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Phase I evaluation of dianhydrogalactitol (NSC-132313).
    Haas CD, Stephens RL, Hollister M, Hoogstraten B.
    Cancer Treat Rep; 1976 May; 60(5):611-4. PubMed ID: 991150
    [Abstract] [Full Text] [Related]

  • 5. Phase II study of single-agent therapy with megestrol acetate, VP-16-213, cyclophosphamide, and dianhydrogalactitol in advanced renal cell cancer.
    Hahn RG, Bauer M, Wolter J, Creech R, Bennett JM, Wampler G.
    Cancer Treat Rep; 1979 Mar; 63(3):513-5. PubMed ID: 371804
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evaluation of VP-16-213 in malignant lymphoma and melanoma.
    Cecil JW, Quagliana JM, Coltman CA, Al-Sarraf M, Thigpen T, Groppe CW.
    Cancer Treat Rep; 1978 May; 62(5):801-3. PubMed ID: 657164
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Preliminary study of the combination, dianhydrogalactitol, cis-diaminedichloroplatinum (II), and VP-16-213 in patients with advanced cancer.
    Creagan ET, Eagan RT, Kvols LK.
    Oncology; 1981 May; 38(5):260-1. PubMed ID: 7196561
    [Abstract] [Full Text] [Related]

  • 12. Preclinical toxicologic evaluation of dianhydrogalactitol in dogs and monkeys.
    Folk RM, Pavkov KL, Thake DC.
    Cancer Treat Rep; 1976 Oct; 60(10):1585-9. PubMed ID: 828520
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Phase II trial of VM-26 in patients with metastatic malignant melanoma.
    Bellet RE, Catalno RB, Mastrangelo MJ, Berd D, Koons LS.
    Cancer Treat Rep; 1978 Mar; 62(3):445-7. PubMed ID: 348313
    [No Abstract] [Full Text] [Related]

  • 16. [Phase II study of etoposide in malignant lymphoma].
    Onoshi T, Hayashi K, Ueoka H, Nishihara R, Toyota K.
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):952-3. PubMed ID: 6721509
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.